Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-066378
Filing Date
2025-07-08
Accepted
2025-07-08 14:11:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 18785
  Complete submission text file 0001104659-25-066378.txt   20646
Mailing Address 1012 SPRINGFIELD AVENUE MOUNTAINSIDE NJ 07092
Business Address 1012 SPRINGFIELD AVENUE MOUNTAINSIDE NJ 07092 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

EIN.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Subject) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89584 | Film No.: 251110596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)